.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Regulation, Policy, and Litigation in Biosimilars

EP. 1: Biosimilar Interchangeability and Market Share

October 30th 2017

EP. 2: Interchangeability and Rheumatology Prescribing Practices

October 30th 2017

EP. 3: Biosimilars, Interchangeability, and Perceptions of Safety

October 30th 2017

EP. 4: Global Reference Products in Biosimilar Development

October 30th 2017

EP. 5: Inspection Reports and Proprietary Information

October 30th 2017

EP. 6: Reforms at the FDA Level

October 30th 2017

EP. 7: Biosimilars, Formularies, Contracting, and PBMs

October 30th 2017

EP. 8: Biosimilar Uptake and Health Plans

October 30th 2017

EP. 9: CMS and Blended Reimbursement Codes

October 30th 2017

EP. 10: Healthcare Reform Efforts and the BPCIA

October 30th 2017